Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4481064 | 0.98 | RNPEP (0.35) | RNPEPALDH1A1 | |
| SCHEMBL4478265 | 0.77 | ALDH1A1 (0.32) | RNPEPALDH1A1 | |
| SCHEMBL4475444 | 0.76 | FFAR3 (0.32) | ALDH1A1 | |
| SCHEMBL137239 | 0.71 | RNPEP (0.33) | RNPEPALDH1A1 | |
| SCHEMBL137240 | 0.71 | RNPEP (0.33) | RNPEPALDH1A1 | |
| SCHEMBL7878320 | 0.70 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL29013093 | 0.70 | RNPEP (0.35) | RNPEPALDH1A1 | |
| SCHEMBL8631296 | 0.70 | RNPEP (0.35) | RNPEPALDH1A1 | |
| SCHEMBL9273470 | 0.69 | CYP2C19 (0.46) | ALDH1A1 | |
| SCHEMBL29100718 | 0.68 | ALDH1A1 (0.33) | RNPEPALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8299293-B2 | Process for preparing α-keto acids and derivatives thereof | EVONIK DEGUSSA GMBH (DE) | 2012-10-30 | — | — | US | disclosed |
| US-20090076302-A1 | PROCESS FOR PREPARING a-KETO ACIDS AND DERIVATIVES THEREOF | EVONIK DEGUSSA GMBH (DE) | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076302-A1 | PROCESS FOR PREPARING a-KETO ACIDS AND DERIVATIVES THEREOF | BCKDK, KHK, ADSL | RNPEP 585/4885ALDH1A1 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.